Analyzing the spectrum of genetic variants in EGFR gene, we found 50 primary and secondary EGFR mutations in 47 NSCLC patients (including 3 mutations co-occurring with other EGFR alterations) (Table 2). This evidence concerns the gene EGFR and non-small cell lung carcinoma.